Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer cell

Showing results (721-730 of 4,103) with videos related to

Pageof 411
Sort By:
Cancer Cell|December 16, 2022
Hyaluronan driven by epithelial aPKC deficiency remodels the microenvironment and creates a vulnerability in mesenchymal colorectal cancerAnxo Martinez-Ordoñez, Angeles Duran, Marc Ruiz-Martinez, et al.
Cancer Cell|December 16, 2022
IL-5-producing CD4<sup>+</sup> T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancerOlga S Blomberg, Lorenzo Spagnuolo, Hannah Garner, et al.
Cancer Cell|December 13, 2022
Towards the development of DCIS risk prediction modelsFariba Behbod, Seema Ahsan Khan
Cancer Cell|December 13, 2022
Tipping the balance: New insights into stromal regulation of cancerJoana Leitão Castro, Janine Terra Erler
Cancer Cell|May 10, 2022
IL-6 blockade in cancer patients treated with immune checkpoint blockade: A win-win strategyJulie Delyon, Celeste Lebbe
Cancer Cell|May 10, 2022
Boosting anticancer immunotherapy through androgen receptor blockadeLaura Pala, Tommaso De Pas, Fabio Conforti
Cancer Cell|May 10, 2022
Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunityYared Hailemichael, Daniel H Johnson, Noha Abdel-Wahab, et al.
Cancer Cell|June 17, 2022
Innate-like T cells: A promising asset in anti-cancer immunityMartina Molgora, Marco Colonna
Cancer Cell|December 30, 2019
Pangenomic Classification of Pituitary Neuroendocrine TumorsMario Neou, Chiara Villa, Roberta Armignacco, et al.
Cancer Cell|September 11, 2020
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in MelanomaCatherine S Grasso, Jennifer Tsoi, Mykola Onyshchenko, et al.
Pageof 411

Showing results (721-730 of 4,103) with videos related to

Sort By:
Pageof 411
Cancer Cell|December 16, 2022
Hyaluronan driven by epithelial aPKC deficiency remodels the microenvironment and creates a vulnerability in mesenchymal colorectal cancerAnxo Martinez-Ordoñez, Angeles Duran, Marc Ruiz-Martinez, et al.
Cancer Cell|December 16, 2022
IL-5-producing CD4<sup>+</sup> T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancerOlga S Blomberg, Lorenzo Spagnuolo, Hannah Garner, et al.
Cancer Cell|December 13, 2022
Towards the development of DCIS risk prediction modelsFariba Behbod, Seema Ahsan Khan
Cancer Cell|December 13, 2022
Tipping the balance: New insights into stromal regulation of cancerJoana Leitão Castro, Janine Terra Erler
Cancer Cell|May 10, 2022
IL-6 blockade in cancer patients treated with immune checkpoint blockade: A win-win strategyJulie Delyon, Celeste Lebbe
Cancer Cell|May 10, 2022
Boosting anticancer immunotherapy through androgen receptor blockadeLaura Pala, Tommaso De Pas, Fabio Conforti
Cancer Cell|May 10, 2022
Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunityYared Hailemichael, Daniel H Johnson, Noha Abdel-Wahab, et al.
Cancer Cell|June 17, 2022
Innate-like T cells: A promising asset in anti-cancer immunityMartina Molgora, Marco Colonna
Cancer Cell|December 30, 2019
Pangenomic Classification of Pituitary Neuroendocrine TumorsMario Neou, Chiara Villa, Roberta Armignacco, et al.
Cancer Cell|September 11, 2020
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in MelanomaCatherine S Grasso, Jennifer Tsoi, Mykola Onyshchenko, et al.
Pageof 411